Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitie Regulatory News (MTO)

Share Price Information for Mitie (MTO)

Share Price is delayed by 15 minutes
Get Live Data
165.00    -5.20 (-3.06%)
Bid:
164.90
Ask:
165.10
Spread: 0.20 (0.121%)
Market Cap: £2.07b
MTO Live PriceLast checked at - London Stock Exchange

Intraday Mitie Share Chart

Transaction in Own Shares

7 Mar 2025 07:00

RNS Number : 7220Z
MITIE Group PLC
07 March 2025
Ā 

07 March 2025

Mitie Group plc

LEI number: 213800MTCLTKEHWZMJ03

Ā 

Mitie Group plc - Transaction in Own Shares

Ā 

Mitie Group plc ("Mitie" or the "Group") today announces that it purchased the following number of its ordinary shares of 2.5 pence each on Exchange (as defined in the Rules of the London Stock Exchange) from Stifel Nicolaus Europe Limited ("Stifel") pursuant to its Share Buyback Programme, details of which were announced on 24 July 2024.

Ā 

Date of purchase:

06/03/2025

Aggregate number of Ordinary 2.5p Shares purchased:

250,000

Lowest price paid per share (GBp):

116.4000

Highest price paid per share (GBp):

117.4000

Volume weighted average price paid per share (GBp):

116.9000

Broker

Stifel

Ā 

Mitie intends to cancel the purchased shares.

Following settlement and cancellation of the above purchase of ordinary shares of 2.5 pence each, Mitie will have 1,263,591,351 ordinary shares of 2.5 pence each in issue (excluding 6,914,367 ordinary shares of 2.5 pence each held in treasury). This figure represents the total number of voting rights in Mitie.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Stifel as part of the buyback programme.

This announcement is made in accordance with the requirements of Listing Rule 12.4.6.

For further information:

Kate Heseltine

Group IR & CorporateFinance Director

Ā 

M: +44 (0)738 443 9112

E:Ā kate.heseltine@mitie.com

Ā 

Claire Lovegrove

Director of Corporate Affairs

M: +44 (0)790 027 6400

Ā 

Ā 

E:Ā claire.lovegrove@mitie.com

Ā 

Richard Mountain

FTI Consulting

Ā 

M: +44 (0)790 968 4466

Schedule of Purchases - Individual Transactions

Number of shares purchased

Transaction price (Gbp)

Venue

Time of transaction

Trade ID

50,000

117.4

XLON

08:53:58

00044717063TRLO1

25,000

117.0

XLON

09:30:16

00044719480TRLO1

25,000

117.0

XLON

10:09:56

00044721647TRLO1

25,000

116.8

XLON

10:49:50

00044723228TRLO1

25,000

116.4

XLON

12:45:28

00044729119TRLO1

25,000

116.6

XLON

13:45:49

00044732135TRLO1

25,000

116.8

XLON

15:22:51

00044740543TRLO1

25,000

116.8

XLON

15:38:24

00044741685TRLO1

25,000

116.8

XLON

15:47:59

00044742622TRLO1

Ā 

Ā 

About Mitie

Ā 

Founded in 1987, Mitie employs 68,000 colleagues and is the leading technology-led Facilities Transformation company in theĀ UK. We are a trusted partner to around 3,000 blue chip customers across the public and private sectors, working with them to transform their built estates, and the lived experience for their colleagues and customers, as well as providing data-driven insights to inform better decision-making.

In each of our core services of Engineering (Hard Services) and Security and Cleaning & Hygiene (Soft Services) we hold market leadership positions. We also upsell Projects capabilities in the areas of building fitouts and modernisation, decarbonisation, fire & security, and telecoms infrastructure. Our sector expertise includes Central Government, Critical National Infrastructure, Defence, Financial Services, Healthcare & Life Sciences, Local Government & Education, Retail & Logistics and Transport & Aviation.

Over the previous Three-Year Plan (FY22 - FY24) Mitie delivered a Total Shareholder Return (TSR) of 80% (#10 inĀ FTSEĀ 250). Our new Facilities Transformation Three-Year Plan (FY25 - FY27) will extend Mitie's market leadership position through accelerated growth and deliver enhanced shareholder returns.

We hold industry-leading ESG credentials, including a place on the CDP Climate change A List, and in the past 12 months we have received multiple industry awards including B2B Marketing Team of the Year, Best Low Carbon Solution and Net Zero Carbon Strategy of the Year. Targeting Net Zero by the end of 2025, our ambitious emissions reduction plans have been validated by the Science Based Targets initiative (SBTi). We have been recognised as aĀ UKĀ Top Employer for the sixth consecutive year. Find out more atĀ www.mitie.com.

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
POSJFMRTMTJMBFA
Date   Source Headline
4th Jun 20267:00 amRNSFull year results for the year ended 31 March 2026
1st Jun 20264:30 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20264:30 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20264:30 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:01 amRNSMitie enhances data centre projects capability
16th Apr 20267:00 amRNSFY26 Trading Update
15th Apr 20264:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20264:45 pmRNSTotal Voting Rights
1st Apr 20264:30 pmRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20264:30 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20265:45 pmRNSTotal Voting Rights
24th Feb 20264:45 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:30 pmRNSDirector/PDMR Shareholding
16th Feb 20264:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.